What is ecnoglutide, the new Chinese weight-loss drug outperforming Ozempic in clinical trials?
In a recent trial of ecnoglutide, developed by Sciwind Biosciences, patients on the highest dose reported an average 15.1 percent weight loss
Protected: Shifting US visa policies are forcing Macao students to rethink their study plans
UPDATED: 28 Jul 2025, 6:10 pm
UPDATED: 28 Jul 2025, 6:10 pm
You might also like
What is ‘Stop Killing Games,’ the video game petition up for consideration by the European Commission?
A global campaign has emerged to put pressure on game developers to stop a practice that many see as a violation of their consumer rights
How to spend your 10,000-pataca handout under Macao’s Wealth Partaking Scheme, according to experts
The Macao government’s annual cash handout can be saved, spent or donated. We’ve asked local professionals and organisations to share some of their ideas